Why Is Semiconductor Company Arm Holdings Stock Trading Higher Monday?
Wells Fargo analyst Gary Mobley initiated coverage on Arm Holdings Plc (NASDAQ: ARM) with an Overweight rating
Dick’s Sporting Goods Emerges As A Promising Buy: Analyst Cites Strong Ties With Nike, On Holding & More
Truist Securities analyst Joseph Civello initiated coverage on Dick's Sporting Goods Inc (NYSE: DKS) with a Buy rating and a
Personal Care Industry Poised For Growth: Analyst Initiates Coverage On These 3 Stocks
Piper Sandler analyst Korinne Wolfmeyer initiated coverage on several personal care stocks, noting that amid the present economic conditions, consumers are becoming more discerning in their spending.
Lululemon’s Brand Loyalty & Expansion Opportunities In Focus, Analyst Sees Attractive Entry-Point For Investors
Truist Securities analyst Joseph Civello initiated coverage on Lululemon Athletica Inc. (NASDAQ: LULU) with a Buy rating and
Cancer Player Revolution Medicines Gets Bullish Rating: Here’s Details
Raymond James initiated coverage on Revolution Medicines Inc (NASDAQ: RVMD), noting that the October readout of RMC-6236 was compelling compared to historical SoC.
This Dental Equipment Maker Has Visible EPS Growth Despite A Challenging Macro: Analyst
Needham initiated coverage on Dentsply Sirona Inc (NASDAQ: XRAY), citing its third turnaround effort since the 2016 Dentsply-Sirona merger.
Docebo Poised To Deliver A Balanced Mix Of Growth & Profitability In FY24: Analyst
Needham analyst Ryan MacDonald initiated coverage on Docebo Inc (NASDAQ: DCBO) with a Buy rating
Anxiety-Focused Stock Vistagen Therapeutics Is An Undervalued Late-Stage Neurology Player: Analyst
Analysts at Stifel recently initiated coverage on Vistagen Therapeutics Inc (NASDAQ: VTGN), emphasizing the potential of its lead asset, fasedienol, in clinical development for social anxiety disorder (SAD).
Why This AMD Analyst Thinks The Chipmaker Can Better Compete With Frontrunner Nvidia In AI Infrastructure Market; Stock ‘A Strong Investment Opportunity’
AMD has a differentiated portfolio and it will hugely benefit from a strong performance by its data center revenue, says a bullish analyst.
Cintas To Thrive In First Aid And Fire Segments, Boosting Margins And Share Repurchases – This Analyst Says
Truist Securities analyst Jasper Bibb initiated coverage on Cintas Corp (NASDAQ: CTAS) with a Buy rating with